Injection/Infusion
NASPALUN FOR INTRAVENOUS INJ
Summary
NASPALUN FOR INTRAVENOUS INJ — Injection/Infusion containing cefoperazone (as sodium), sulbactam (as sodium). Hong Kong Registration No. HK-56893. Certificate Holder: MAIN LIFE CORP LTD. Date of Registration: 15 Aug, 2008.
Product NameNASPALUN FOR INTRAVENOUS INJ
Registration No.HK-56893
Certificate HolderMAIN LIFE CORP LTD
Holder Address9/F & 16/F, WINNING CENTRE, 46-48 WYNDHAM STREET, CENTRAL, HONG KONG
Ingredientscefoperazone (as sodium), sulbactam (as sodium)
Dosage FormInjection/Infusion
Legal ClassificationAntibiotic
Sale RequirementPrescription only Medicines
Date of Registration15 Aug, 2008
ATC codesJ01CG01, J01DD12
ATC Classification
ATC level 1
J Antiinfectives for Systemic Use
All ATC groupsJ01
This product contains more than one active ingredient. The ATC groups above describe the ingredients, not a single category for the product as a whole.
本頁為藥物資料查詢工具，並非藥物廣告、推廣或醫療建議。所有資料取自香港特別行政區衞生署藥物辦公室之公開資料，僅供參考；一切以藥物辦公室官方公布為準。 本頁不提供任何療效、適應症或治療用途之陳述。用藥前請諮詢醫生或註冊藥劑師。 本網站遵守香港法例第 231 章《不良廣告（醫藥）條例》之規管。